Ondine Biomedical, Inc. (GB:OBI) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Ondine Biomedical Inc., a Canadian life sciences company, is set to raise at least £8.5 million through a fundraising initiative involving new common shares. The funds will primarily support a U.S. Phase 3 clinical study for its nasal photodisinfection system, with additional financial backing potentially extending their cash runway into 2026. This fundraising effort is crucial for advancing their clinical trials and bolstering working capital.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.
